Please login to the form below

Not currently logged in
Email:
Password:

Proteostasis

This page shows the latest Proteostasis news and features for those working in and with pharma, biotech and healthcare.

Setback for Vertex’s cystic fibrosis challenger Proteostasis

Setback for Vertex’s cystic fibrosis challenger Proteostasis

In contrast, Proteostasis’ triplet therapy failed to show a significant improvement in the measure of patients' lung function referred to as ppFEV1. ... The news sent Proteostasis shares crashing down 63% yesterday - while analysts upgraded forecasts

Latest news

  • Vertex rises on data for cystic fibrosis triple therapy Vertex rises on data for cystic fibrosis triple therapy

    competition to Vertex could come from Proteostasis, which has already reported impressive data with a two-drug regimen and has a triple study due to read out in the coming weeks.

  • AbbVie and C2N take tau antibody into clinic AbbVie and C2N take tau antibody into clinic

    Meanwhile, Biogen licensed rights to a tau-targeting compound in development at Eisai for Alzheimer's in March, while Astellas signed a $1.2bn agreement with Proteostasis Therapeutics last November that

  • Astellas earmarks up to $1.2bn for protein folding research Astellas earmarks up to $1.2bn for protein folding research

    Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed

  • Eastern Europe targeted

    Licence.  83. Proteostasis/Elan. Discovery of disease-modifying small molecules for the treatment of neurodegenerative disorders.

  • Eisai/ UCL partnership grows

    The new phase will see the Eisai and UCL engage in joint research in neurodegenerative disease including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Proteostasis Therapeutics strengthens leadership team Proteostasis Therapeutics strengthens leadership team

    James DeTore, Geoffrey Gilmartin and Marija Zecevic join. Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments. ... Lastly, Dr Marija Zecevic takes on the role of vice president of

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....

Infographics